首页> 外文会议>32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society >A signal processing-based Bioinformatics approach to assessing drug resistance: Human Immunodeficiency Virus as a case study
【24h】

A signal processing-based Bioinformatics approach to assessing drug resistance: Human Immunodeficiency Virus as a case study

机译:基于信号处理的生物信息学方法评估耐药性:以人类免疫缺陷病毒为例

获取原文

摘要

Measuring drug resistance is one of the challenging and essential pharmaceutical activities. It is a laborious and costly laboratory-based experimentation. Various clinical and experimental analyses for measuring drug resistance have been carried out. Results have been obtained for different types of therapeutic agents as a consequence of changes in the amino acids compositions in the sequence (mutation) of the organisms involved. In the same manner, the positions of these amino acids alterations and the level of resistance (folds) have also been experimentally identified. For example, G36S and V38M mutation in the Human Immunodeficiency Virus (HIV) Transmembrane glycoprotein (gp41) has been found to cause 100-fold resistance. However, there does not seem to have bioinformatics method developed in which the amino acid information of the proteins involved in the studies were used to computationally assess the degree of drug resistance without involving laboratory-based experimental procedure. The post-genomic era has witnessed the relevance of Bioinformatics approaches in the analysis of huge biomedical data. One such approach is the analysis of protein residues using digital signal processing technique such as informational spectrum method (ISM). Therefore, we propose a new bioinformatics method that is capable of assessing drug resistance without the use of any laboratory-based experiments. This new method incorporates ISM, sequence information of the proteins and other relevant information. By using the ISM and EIIP amino acid scale, the technique was applied in three classes of anti-HIV/AIDS drugs as a case study. It is observed that the protein residues of the susceptible strains attained the maximal peak amplitude at the consensus frequency while the resistant strains maintained lower amplitudes. This result signifies lower contribution from the resistant strains due to the mutation. The findings are consistent with those of the experimental ones and therefore --suggest that the approach taken can be used to help assess drug resistance without laboratory-based experimentation. It should also be noted that the method can be applied in other drug resistance studies where sequence information of proteins is available and help design a computer-aided drug resistance calculator.
机译:测量抗药性是具有挑战性的基本药物活动之一。这是一项费力且昂贵的基于实验室的实验。已经进行了用于测量耐药性的各种临床和实验分析。由于所涉及生物的序列(突变)中氨基酸组成的变化,已经获得了不同类型治疗剂的结果。以相同的方式,这些氨基酸改变的位置和抗性水平(倍数)也已通过实验确定。例如,已发现人类免疫缺陷病毒(HIV)跨膜糖蛋白(gp41)中的G36S和V38M突变引起100倍的耐药性。然而,似乎还没有开发出生物信息学方法,其中不涉及基于实验室的实验程序,而是将参与研究的蛋白质的氨基酸信息用于计算评估耐药性的程度。后基因组时代见证了生物信息学方法在分析巨大的生物医学数据中的相关性。一种这样的方法是使用数字信号处理技术(例如信息频谱方法(ISM))分析蛋白质残留。因此,我们提出了一种新的生物信息学方法,该方法无需使用任何基于实验室的实验就能够评估药物耐药性。这种新方法结合了ISM,蛋白质的序列信息和其他相关信息。通过使用ISM和EIIP氨基酸量表,将该技术应用于三类抗HIV / AIDS药物作为案例研究。观察到,敏感菌株的蛋白质残基在共有频率处达到最大峰幅度,而抗性菌株则保持较低幅度。该结果表明由于突变,抗性菌株的贡献较低。研究结果与实验结果一致,因此- -- 建议采用的方法无需实验室为基础的实验即可用于评估耐药性。还应注意的是,该方法可用于其他可获得蛋白质序列信息的药物耐药性研究中,并有助于设计计算机辅助的药物耐药性计算器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号